CDER Drug Safety Labeling Changes - 9/2/2022

Drug Safety-related Labeling Changes (SrLC) The SrLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated ALIMTA PEMETREXED DISODIUM 021462 NDA 08/31/2022 09/01/2022 DIPRIVAN PROPOFOL 019627 NDA 08/31/2022 09/01/2022 FUROSEMIDE FUROSEMIDE 018667 NDA 08/31/2022 09/01/2022 SYNTHROID LEVOTHYROXINE SODIUM 021402 NDA 08/30/2022 09/01/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA